The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 690-696

  Wu, Jia Feng ^a   Hsu, Hong Yuan ^a   Chiu, Yu Chun ^a   Chen, Huey Ling ^a   Ni, Yen Hsuan ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 4;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CYTOKINE GENE; FEMALE; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; HUMAN CELL; IFN GAMMA GENE; IL 10 GENE; IL 12BETA GENE; IL 13 GENE; IL 1BETA GENE; IL 2 GENE; IL 27 GENE; IL 4 GENE; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; CELLULAR IMMUNITY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FOLLOW UP; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 84920374640     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401659     Document Type: Article

References (34)

1. Beasley, R. P., L. Y. Hwang, C. C. Lin, and C. S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2: 1129-1133.
2. Lertkhachonsuk, A. A., C. H. Yip, T. Khuhaprema, D. S. Chen, M. Plummer, S. H. Jee, M. Toi, and S. Wilailak, Asian Oncology Summit 2013. 2013. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 14: e497-e507.
3. Chu, C. M., and Y. F. Liaw. 2010. Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir. Ther. (Lond.) 15: 133-143.
4. Hsu, H. Y., M. H. Chang, C. Y. Lee, J. S. Chen, H. C. Hsu, and D. S. Chen. 1992. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 15: 382-386.
5. Tseng, T. C., C. J. Liu, T. H. Su, C. C. Wang, C. L. Chen, P. J. Chen, D. S. Chen, and J. H. Kao. 2011. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology 141: 517- 525, e1-e2.
6. Marx, G., S. R. Martin, J. F. Chicoine, and F. Alvarez. 2002. Long-term follow up of chronic hepatitis B virus infection in children of different ethnic origins. J. Infect. Dis. 186: 295-301.
7. Bortolotti, F., M. Guido, S. Bartolacci, P. Cadrobbi, C. Crivellaro, F. Noventa, G. Morsica, M. Moriondo, and A. Gatta. 2006. Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study. Hepatology 43: 556-562.
8. Thursz, M. R., D. Kwiatkowski, C. E. Allsopp, B. M. Greenwood, H. C. Thomas, and A. V. Hill. 1995. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 332: 1065-1069.
9. Nishida, N., H. Sawai, K. Matsuura, M. Sugiyama, S. H. Ahn, J. Y. Park, S. Hige, J. H. Kang, K. Suzuki, M. Kurosaki, et al. 2012. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 7: e39175.
10. Cheng, H. R., C. J. Liu, T. C. Tseng, T. H. Su, H. I. Yang, C. J. Chen, and J. H. Kao. 2013. Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients. PLoS ONE 8: e53008.
11. Chu, C. M., and Y. F. Liaw. 2012. Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers. Clin. Infect. Dis. 54: 88-90.
12. Wu, J. F., Y. R. Su, C. H. Chen, H. L. Chen, Y. H. Ni, H. Y. Hsu, J. L. Wang, and M. H. Chang. 2012. Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children. J. Pediatr. Gastroenterol. Nutr. 54: 97-100.
13. Kao, P. C., J. F. Wu, Y. H. Ni, Y. T. Lin, H. L. Chen, S. H. Hsu, H. Y. Hsu, and M. H. Chang. 2010. Tumour necrosis factor-a promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int. 30: 1448-1453.
14. Takakura, M., K. Tokushige, N. Matsushita, E. Hashimoto, and K. Shiratori. 2007. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J. Gastroenterol. Hepatol. 22: 1271-1277.
15. Wu, J. F., T. C. Wu, C. H. Chen, Y. H. Ni, H. L. Chen, H. Y. Hsu, and M. H. Chang. 2010. Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 138: 165-172, e1-e3.
16. Wu, J. F., H. Y. Hsu, Y. H. Ni, H. L. Chen, T. C. Wu, and M. H. Chang. 2012. Suppression of furin by interferon-g and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes. Am. J. Pathol. 181: 19-25.
17. Yeh, S. H., C. Y. Tsai, J. H. Kao, C. J. Liu, T. J. Kuo, M. W. Lin, W. L. Huang, S. F. Lu, J. Jih, D. S. Chen, and P. J. Chen. 2004. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J. Hepatol. 41: 659-666.
18. Hsu, H. Y., M. H. Chang, Y. H. Ni, H. H. Lin, S. M. Wang, and D. S. Chen. 1997. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26: 786-791.
19. Su, W. J., C. C. Liu, D. P. Liu, S. F. Chen, J. J. Huang, T. C. Chan, and M. H. Chang. 2012. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J. Infect. Dis. 205: 757-762.
20. Mu, S. C., Y. M. Lin, G. M. Jow, and B. F. Chen. 2009. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J. Hepatol. 50: 264-272.
21. Shi, Y., Y. H. Wu, W. Wu, W. J. Zhang, J. Yang, and Z. Chen. 2012. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: A meta-analysis. Liver Int. 32: 231-240.
22. Lin, T. M., C. J. Chen, M. M.Wu, C. S. Yang, J. S. Chen, C. C. Lin, T. Y. Kwang, S. T. Hsu, S. Y. Lin, and L. C. Hsu. 1989. Hepatitis B virus markers in Chinese twins. Anticancer Res. 9: 737-741.
23. Bozkaya, H., M. Bozdayi, R. Türkyilmaz, M. Sarioglu, H. Cetinkaya, K. Cinar, K. Köse, C. Yurdaydin, and O. Uzunalimoglu. 2000. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: Their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47: 1675-1679.
24. Miyazoe, S., K. Hamasaki, K. Nakata, Y. Kajiya, K. Kitajima, K. Nakao, M. Daikoku, H. Yatsuhashi, M. Koga, M. Yano, and K. Eguchi. 2002. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 97: 2086-2092.
25. Santin, A. D., P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon. 2000. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J. Virol. 74: 4729-4737.
26. Mack, C. L., R. M. Tucker, R. J. Sokol, F. M. Karrer, B. L. Kotzin, P. F. Whitington, and S. D. Miller. 2004. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr. Res. 56: 79-87.
27. Schurich, A., L. J. Pallett, M. Lubowiecki, H. D. Singh, U. S. Gill, P. T. Kennedy, E. Nastouli, S. Tanwar, W. Rosenberg, and M. K. Maini. 2013. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 9: e1003208.
28. Ethuin, F., C. Delarche, M. A. Gougerot-Pocidalo, B. Eurin, L. Jacob, and S. Chollet-Martin. 2003. Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis. Lab. Invest. 83: 1353-1360.
29. Rigopoulou, E. I., D. Suri, S. Chokshi, I. Mullerova, S. Rice, R. S. Tedder, R. Williams, and N. V. Naoumov. 2005. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity. Hepatology 42: 1028-1036.
30. Carreño, V., S. Zeuzem, U. Hopf, P. Marcellin, W. G. Cooksley, J. Fevery, M. Diago, R. Reddy, M. Peters, K. Rittweger, et al. 2000. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J. Hepatol. 32: 317-324.
31. Lainé, S., A. Thouard, J. Derancourt, M. Kress, D. Sitterlin, and J. M. Rossignol. 2003. In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR. J. Virol. 77: 12875-12880.
32. Scaglioni, P. P., M. Melegari, and J. R. Wands. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 71: 345-353.
33. Cameron, L., R. B. Webster, J. M. Strempel, P. Kiesler, M. Kabesch, H. Ramachandran, L. Yu, D. A. Stern, P. E. Graves, I. C. Lohman, et al. 2006. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C.T, a polymorphism associated with allergic inflammation. J. Immunol. 177: 8633- 8642.
34. Jin, Z., R. Sun, H. Wei, X. Gao, Y. Chen, and Z. Tian. 2011. Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells. Hepatology 53: 219-229.